<DOC>
	<DOC>NCT01229527</DOC>
	<brief_summary>The purpose of this randomized double-blind trial is to define the correct dosage of Remifentanil during operative and diagnostic endoscopic procedures. In particular we want to analyze if the administration of Remifentanil by PCSA (Patient Controlled Sedation and Analgesia) is a good method during colonoscopy, evaluating pain control, discharge time and side effects. 90 patients undergoing colonoscopy will be enrolled.</brief_summary>
	<brief_title>Comparison Between Two Different Dosages of Remifentanil During Colonoscopy</brief_title>
	<detailed_description />
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Meperidine</mesh_term>
	<criteria>Adult Patients Diagnostic and Operative Colonoscopy ASA Physical Status III Age &lt; 18 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Colonoscopy</keyword>
	<keyword>Remifentanil</keyword>
	<keyword>Sedation</keyword>
</DOC>